Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Adocia ACT (OTC: ADOCY).

Full DD Report for ADOCY

You must become a subscriber to view this report.


Recent News from (OTC: ADOCY)

Snippet Roundup: Biogen's Chief Exec Choice Underwhelms As A Big 2016 Decision Is Delayed To 2017
Welcome to your weekly roundup of EP Vantage’s snippets – short takes on smaller news items. This week, December 19-23, 2016, we had thoughts on the following: manufacturing review delays Ocrevus launch; Japan tightens pricing screw with annual review; Bioinvent (BOVNF) couples...
Source: SeekingAlpha
Date: December, 23 2016 14:08
A European Biotech Stock Basket For 2016 - Update
This article is a follow up to the article entitled " A European Biotech Stock Basket For 2016 " published earlier this year and which is part of an ongoing yearly "basket" selection of European biotechs of interest. The purpose of this series is to review a selection of European small to mid-...
Source: SeekingAlpha
Date: October, 03 2016 12:55
Adocia: Official Focus On Diabetes Next Logical Step To Success
Note: Investors should be mindful of the risks of transacting in securities with limited liquidity, such as Adocia ( ADOCF) ( ADOCY) . Adocia SAS trades with more liquidity on the Paris exchange as ADOC.PA. INTRODUCTION Adocia (ADOCY) is a leading developer of innovative formulati...
Source: SeekingAlpha
Date: June, 29 2016 13:08
A European Biotech Stock Basket For 2016
One year ago, I published an article entitled "A European Biotech Stock Basket For 2015" followed by an update around mid-year. The purpose of these articles was to review a selection of European micro-cap biotechs of interest, which shared a combination of strong fundamentals and apparent...
Source: SeekingAlpha
Date: January, 27 2016 08:04
Adocia: Clinical Research Intensifies
Note: Investors should be mindful of the risks of transacting in securities with limited liquidity, such as Adocia ( ADOCF) ( ADOCY) . Adocia SAS trades with more liquidity on the Paris exchange as ADOC.PA. Introduction If you are not familiar with Adocia SAS, I recommend readin...
Source: SeekingAlpha
Date: October, 26 2015 16:37

 


About Adocia ACT (OTC: ADOCY)

Logo for Adocia ACT (OTC: ADOCY)

ADOCIA is a biotechnology company specialized in the development of best in class medicines from already approved therapeutic agents

 

Contact Information

 

 

Current Share Structure

     



    Daily Technical Chart for (OTC: ADOCY)

    Daily Technical Chart for (OTC: ADOCY)


    Stay tuned for daily updates and more on (OTC: ADOCY)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: ADOCY)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    Monsta Trader
    @MonstaTrader

     

     


    Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ADOCY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of ADOCY and does not buy, sell, or trade any shares of ADOCY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/